APA (7th ed.) Citation

Lachno, D. R., Evert, B. A., Vanderstichele, H., Robertson, M., Demattos, R. B., Konrad, R. J., . . . Dean, R. A. (2013). Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab. Journal of Alzheimer's disease, 34(4), 897. https://doi.org/10.3233/JAD-122317

Chicago Style (17th ed.) Citation

Lachno, D Richard, Barbara A. Evert, Hugo Vanderstichele, Michael Robertson, Ronald B. Demattos, Robert J. Konrad, Jayne A. Talbot, Margaret M. Racke, and Robert A. Dean. "Validation of Assays for Measurement of Amyloid-β Peptides in Cerebrospinal Fluid and Plasma Specimens from Patients with Alzheimer's Disease Treated with Solanezumab." Journal of Alzheimer's Disease 34, no. 4 (2013): 897. https://doi.org/10.3233/JAD-122317.

MLA (9th ed.) Citation

Lachno, D Richard, et al. "Validation of Assays for Measurement of Amyloid-β Peptides in Cerebrospinal Fluid and Plasma Specimens from Patients with Alzheimer's Disease Treated with Solanezumab." Journal of Alzheimer's Disease, vol. 34, no. 4, 2013, p. 897, https://doi.org/10.3233/JAD-122317.